Global TB Consilium

About Us

The Global TB Consilium: a response to difficult-to-treat TB cases

The Global TB Consilium is supported by the Global TB Network (GTN) and operates within WAidid (World Association Infectious Diseases and Immunological Disorders), a scientific society offering free-cost membership. A specific global expert Committee supports the TB Consilium

What is The Global TB Consilium?

It is a free-cost electronic consultation initiative providing clinicians with expert opinion on challenging cases of TB within 48 hours on a secure platform in different languages (English, Russian, Spanish, Portuguese and Italian).

The aims of the Global TB Consilium are to:

  • Improve the clinical management of difficult-to-treat TB cases or micro-epidemics (including TB/HIV and paediatric cases and latent TB infection) and prevent the emergence of further drug-resistance
  • Provide evidence-based advice to support physicians in managing diagnosis and treatment of MDR/XDR-TB cases (special focus on rationale use of new drugs/regimens and their compassionate use, and management of adverse events)
  • Support the management of trans-border migration TB cases

Follow these steps to submit a case and ask for clinical advice:

  1. Fill in online the Patient Form with anonymised clinical information (GDPR rules)
  2. Receive a prompt expert advice (48 hours) in your TB Consilium account (you will be notified via e-mail)
  3. Pretomanid?

For trans-border migration TB cases, provide us with relevant information here

Our Team